HOMEVIEW DEVELOPMENT, LLC – Trademark Portfolio
Entity Type: 16
HOMEVIEW DEVELOPMENT, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 37 (Building & Construction) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 8 are pending. Notable registered marks include B and BOSSCAT. The owner is based in DENVER, CO.
5075 S SYRACUSE ST
DENVER, CO 80237
Showing of trademarks Trademarks
Trademark Classifications
HOMEVIEW DEVELOPMENT, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does HOMEVIEW DEVELOPMENT, LLC have?
HOMEVIEW DEVELOPMENT, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 8 pending.
What trademark classes does HOMEVIEW DEVELOPMENT, LLC file in?
HOMEVIEW DEVELOPMENT, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 37 (Building & Construction), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 37 covers building construction; repair; installation services.
What are HOMEVIEW DEVELOPMENT, LLC's most well-known trademarks?
HOMEVIEW DEVELOPMENT, LLC's registered trademark portfolio includes well-known marks such as B and BOSSCAT. These are among 2 currently registered trademarks in the portfolio.
What is HOMEVIEW DEVELOPMENT, LLC's trademark registration success rate?
HOMEVIEW DEVELOPMENT, LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 8 applications are pending review.